New hope for migraine sufferers: atogepant under Real-World study
NCT ID NCT06414044
First seen Jan 23, 2026 · Last updated May 11, 2026 · Updated 14 times
Summary
This study looks at how well the drug atogepant works to prevent migraines in everyday life. About 500 adults with migraine (with or without aura) will take atogepant and report their migraine days over a year. The goal is to see if it reduces migraine frequency and is safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Campus Bio-Medico
Roma, 00128, Italy
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, 50134, Italy
Conditions
Explore the condition pages connected to this study.